# John A. Spertus

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/john-a-spertus/

## Facts

| Field | Value |
| --- | --- |
| Citations | 124,560 |
| Field | Acute Myocardial Infarction Research |
| h-index | 153 |
| i10-index | 919 |
| Last Known Institution | Saint Luke's Health System |
| OpenAlex ID | https://openalex.org/A5015021993 |
| ORCID iD | 0000-0002-2839-2611 |
| Works | 1,970 |

## Researcher papers

Showing 12 of 41.

- [Diagnosis and Management of the Metabolic Syndrome](https://scholariq.org/papers/diagnosis-and-management-of-the-metabolic-syndrome/)
- [Optimal Medical Therapy with or without PCI for Stable Coronary Disease](https://scholariq.org/papers/optimal-medical-therapy-with-or-without-pci-for-stable-coronary-disease/)
- [Initial Invasive or Conservative Strategy for Stable Coronary Disease](https://scholariq.org/papers/initial-invasive-or-conservative-strategy-for-stable-coronary-disease/)
- [2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease: Executive Summary](https://scholariq.org/papers/2012-accf-aha-acp-aats-pcna-scai-sts-guideline-for-the-diagnosis-and-management/)
- [w2145813488](https://scholariq.org/papers/w2145813488/)
- [Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure](https://scholariq.org/papers/development-and-evaluation-of-the-kansas-city-cardiomyopathy-questionnaire-a-new/)
- [AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update](https://scholariq.org/papers/aha-accf-secondary-prevention-and-risk-reduction-therapy-for-patients-with/)
- [Diagnosis and Management of the Metabolic Syndrome](https://scholariq.org/papers/diagnosis-and-management-of-the-metabolic-syndrome-2/)
- [Optimal Medical Therapy With or Without Percutaneous Coronary Intervention to Reduce Ischemic Burden](https://scholariq.org/papers/optimal-medical-therapy-with-or-without-percutaneous-coronary-intervention-to/)
- [Medical Therapy for Heart Failure With Reduced Ejection Fraction](https://scholariq.org/papers/medical-therapy-for-heart-failure-with-reduced-ejection-fraction/)
- [Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants](https://scholariq.org/papers/genome-wide-association-of-early-onset-myocardial-infarction-with-single/)
- [Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document](https://scholariq.org/papers/standardized-end-point-definitions-for-coronary-intervention-trials-the-academic/)

## Researcher topics

- [Acute Myocardial Infarction Research](https://scholariq.org/topics/acute-myocardial-infarction-research/)
- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Cardiac Imaging and Diagnostics](https://scholariq.org/topics/cardiac-imaging-and-diagnostics/)
- [Cardiac Health and Mental Health](https://scholariq.org/topics/cardiac-health-and-mental-health/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)

## Researcher university

- [Saint Luke's Health System](https://scholariq.org/institutions/saint-luke-s-health-system/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.